Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Prestige Consumer Healthcare (PBH) Invested Capital: 2009-2025

Historic Invested Capital for Prestige Consumer Healthcare (PBH) over the last 17 years, with Mar 2025 value amounting to $2.8 billion.

  • Prestige Consumer Healthcare's Invested Capital rose 1.25% to $2.8 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.8 billion, marking a year-over-year increase of 1.25%. This contributed to the annual value of $2.8 billion for FY2025, which is 1.67% up from last year.
  • Latest data reveals that Prestige Consumer Healthcare reported Invested Capital of $2.8 billion as of FY2025, which was up 1.67% from $2.8 billion recorded in FY2024.
  • Prestige Consumer Healthcare's Invested Capital's 5-year high stood at $3.1 billion during FY2022, with a 5-year trough of $2.8 billion in FY2024.
  • Its 3-year average for Invested Capital is $2.8 billion, with a median of $2.8 billion in 2023.
  • In the last 5 years, Prestige Consumer Healthcare's Invested Capital grew by 7.62% in 2022 and then fell by 8.56% in 2023.
  • MRY analysis of 5 years shows Prestige Consumer Healthcare's Invested Capital stood at $2.8 billion in 2021, then rose by 7.62% to $3.1 billion in 2022, then dropped by 8.56% to $2.8 billion in 2023, then decreased by 0.43% to $2.8 billion in 2024, then increased by 1.67% to $2.8 billion in 2025.
  • Its last three reported values are $2.8 billion in FY2025, $2.8 billion for FY2024, and $2.8 billion during FY2023.